-
No.296
すぐ提携が決まるんなら普通その…
2023/07/12 13:35
すぐ提携が決まるんなら普通その後にワラントするだろ
提携知っててその前にワラントするとかインサイダーだから -
2023/06/26 20:04
-
No.1118
Pfizer Provides…
2023/06/26 19:52
Pfizer Provides Update on GLP-1-RA Clinical Development Program for Adults with Obesity and Type 2 Diabetes Mellitus
Pfizer is continuing to advance the first full agonist oral GLP-1-RA candidate danuglipron toward late-state development
Danuglipron is the largest oral, small molecule GLP-1-RA clinical development program underway with over 1,400 participants enrolled for the treatment of obesity and T2DM
Ongoing danuglipron Phase 2b study in obesity is fully enrolled
Second GLP-1-RA candidate lotiglipron to be discontinued -
No.120
FDA delays deci…
2023/05/25 07:16
FDA delays decision on Sarepta's Duchenne gene therapy until June 22
-
No.658
Lilly's $LLY Do…
2023/05/03 19:37
Lilly's $LLY Donanemab Significantly Slowed Cognitive and Functional Decline in Phase 3 Study of Early Alzheimer's Disease
-
No.716
Today Biogen an…
2023/04/25 21:00
Today Biogen announced that it is pausing the initiation of a Phase 2b study for BIIB131 (TMS-007) for acute ischemic stroke and is assessing whether to initiate this study.
Re:でも前からワラントするっち言い…
2023/07/12 15:04
何も理解してなくて草